Literature DB >> 14670800

Cytokine secretion by cystic fibrosis airway epithelial cells.

Marie N Becker1, Mariam S Sauer, Marianne S Muhlebach, Andrew J Hirsh, Qi Wu, Margrith W Verghese, Scott H Randell.   

Abstract

It is controversial whether mutations in cystic fibrosis transmembrane conductance regulator intrinsically dysregulate inflammation. We characterized passage 2 human tracheobronchial epithelial cell cultures morphologically and physiologically and determined whether cytokine production or nuclear factor-kappaB activation was systematically altered in cystic fibrosis (CF) cells. Non-CF and CF cells originating from a total of 33 and 25 lungs, respectively, were available for culture on plastic or at an air-liquid interface until well differentiated. Forskolin-stimulated short-circuit currents were present in representative polarized non-CF cultures and were absent in CF cultures, whereas uridine 5'-triphosphate-stimulated currents were present in both. Constitutive or interleukin (IL)-1beta-induced IL-8 or IL-6 secretion or nuclear factor-kappaB activity was not significantly different between non-CF and CF cells. The cytokines regulated upon activation, normal T cell expressed and secreted (RANTES) and IL-10 were not detectable. Stimulation with tumor necrosis factor-alpha or a synthetic toll-like receptor 2 agonist or variable doses and times of Staphylococcus aureus culture filtrate revealed a single dose- and time-dependent difference in IL-8 production by CF cells. Interestingly, although IL-8 secretion after stimulation with Pseudomonas aeruginosa filtrates was not greater in CF cells in the absence of human serum, it was variably greater in its presence. Thus, although exaggerated responses may develop under certain conditions, our results do not support an overall intrinsically hyperinflammatory phenotype in CF cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14670800     DOI: 10.1164/rccm.200207-765OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  45 in total

1.  Pediatric Respiratory Assembly. Mini symposium on lung inflammation.

Authors:  Larry C Lands; A Keith Tanswell; Sophie Laberge; Christine McCusker; Felix Ratjen
Journal:  Can Respir J       Date:  2010 Mar-Apr       Impact factor: 2.409

2.  Nonclassical pathway of Pseudomonas aeruginosa DNA-induced interleukin-8 secretion in cystic fibrosis airway epithelial cells.

Authors:  Mónica A Delgado; Jens F Poschet; Vojo Deretic
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Alveolar inflammation in cystic fibrosis.

Authors:  Martina Ulrich; Dieter Worlitzsch; Simona Viglio; Nanna Siegmann; Paolo Iadarola; Janis K Shute; Marianne Geiser; Gerald B Pier; Godehard Friedel; Mark L Barr; Antje Schuster; Keith C Meyer; Felix Ratjen; Thomas Bjarnsholt; Erich Gulbins; Gerd Döring
Journal:  J Cyst Fibros       Date:  2010-03-29       Impact factor: 5.482

4.  CrossTalk proposal: Skeletal muscle oxidative capacity is altered in patients with cystic fibrosis.

Authors:  Paula Rodriguez-Miguelez; Melissa L Erickson; Kevin K McCully; Ryan A Harris
Journal:  J Physiol       Date:  2017-03-01       Impact factor: 5.182

5.  CrossTalk proposal: mucosal acidification drives early progressive lung disease in cystic fibrosis.

Authors:  Miriam F Figueira; Megan J Webster; Robert Tarran
Journal:  J Physiol       Date:  2018-07-17       Impact factor: 5.182

6.  Inhibition of p38 mitogen activated protein kinase controls airway inflammation in cystic fibrosis.

Authors:  V Raia; L Maiuri; C Ciacci; I Ricciardelli; L Vacca; S Auricchio; M Cimmino; M Cavaliere; M Nardone; A Cesaro; J Malcolm; S Quaratino; M Londei
Journal:  Thorax       Date:  2005-06-30       Impact factor: 9.139

7.  Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells.

Authors:  Cristina Cigana; Baroukh Maurice Assael; Paola Melotti
Journal:  Antimicrob Agents Chemother       Date:  2007-01-08       Impact factor: 5.191

8.  Assessment of biological responses of EpiAirway 3-D cell constructs versus A549 cells for determining toxicity of ambient air pollution.

Authors:  Jose Zavala; Bridget O'Brien; Kim Lichtveld; Kenneth G Sexton; Ivan Rusyn; Ilona Jaspers; William Vizuete
Journal:  Inhal Toxicol       Date:  2016       Impact factor: 2.724

9.  Neutrophil cell death, activation and bacterial infection in cystic fibrosis.

Authors:  A P Watt; J Courtney; J Moore; M Ennis; J S Elborn
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

10.  Inhibition of NFkappaB by the natural product Withaferin A in cellular models of Cystic Fibrosis inflammation.

Authors:  Rangan Maitra; Melissa A Porter; Shan Huang; Brian P Gilmour
Journal:  J Inflamm (Lond)       Date:  2009-05-13       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.